2025年度ï¼ä»¤å7年度ï¼è¬ä¾¡ä¸éå¹´æ¹å®ãè²»ç¨å¯¾å¹æè©ä¾¡ åã³ç¾©åçãªåµè¬æ¯æ´åºéã«é¢ããå
±å声æ / Joint Statement on FY2025 Off-Year Drug Price Revision Outcome, Cost-Effectiveness Evaluations and Mandatory Drug Discovery Support Fund PhRMA - ç±³å½ç 究製è¬å·¥æ¥åä¼ > ãã¬ã¹ã«ã¼ã > ãã¬ã¹ãªãªã¼ã¹ > 2024å¹´ã®ãã¬ã¹ãªãªã¼ã¹ > 2025年度ï¼ä»¤å7年度ï¼è¬ä¾¡ä¸éå¹´æ¹å®ãè²»ç¨å¯¾å¹æè©ä¾¡ åã³ç¾©åçãªåµè¬æ¯æ´åºéã«é¢ããå
±å声æ / Joint Statement on FY2025 Off-Year Drug Price Revision Outcome, Cost-Effectiveness Evaluations and Mand